Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-12

Clinical Trial Update: Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating different cycles of cisplatin plus 5-fluorouracil chemoradiotherapy for esophageal squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN